Abstract
Colloidal nanoparticles (NPs) are a versatile potential platform for in vivo nanomedicine. Inside blood circulation, NPs may undergo drastic changes, such as by formation of a protein corona. The in vivo corona cannot be completely emulated by the corona formed in blood. Thus, in situ detection in complex media, and ultimately in vivo, is required. Here we present a methodology for determining protein corona formation in complex media. NPs are labeled with 19F and their diffusion coefficient measured using 19F diffusion-ordered nuclear magnetic resonance (NMR) spectroscopy. 19F diffusion NMR measurements of hydrodynamic radii allow for in situ characterization of NPs in complex environments by quantification of protein adsorption to the surface of NPs, as determined by increase in hydrodynamic radius. The methodology is not optics based, and thus can be used in turbid environments, as in the presence of cells.
In situ detection of protein coronas is usually performed via optical methods, but light scattering may hamper these measurements. Here, the authors use diffusion NMR techniques to characterize protein corona formation on 19F-labeled nanoparticles in blood and other complex media.
Introduction
Colloidal nanoparticles (NPs) are a versatile potential platform for in vivo nanomedicine1. Inside the blood circulation, the NPs may undergo drastic changes, e.g., by the formation of a protein corona2. The dynamic development of protein corona formation has been studied extensively by mass spectroscopy or other techniques3. Such measurements have been performed in relevant solutions such as blood4, which, however, requires extraction of the NPs and removal of unbound excess proteins, leading to a loss of the equilibrium properties5. Alternatively, protein corona formation can be observed based on measuring the associated increase in the NPs’ hydrodynamic radius and reduction in diffusion coefficient5. In case only protein–NP complexes, but no free proteins, are subject to diffusion coefficient measurements, protein corona formation can be quantified in situ, without removal of excess proteins6,7. Several optical methods, such as fluorescence correlation spectroscopy (FCS)6 or depolarized dynamic light scattering (DDLS)7, have been established for in situ quantification based on diffusion coefficient measurements. However, in complex media such as blood or even tissue, optical detection suffers from light scattering. Unfortunately, the in vivo corona cannot be completely emulated by the corona formed in blood, etc8. Thus, in situ detection in complex media, i.e., ultimately in vivo, is required.
In this work, we present a non-optical methodology for determining protein corona formation in complex media. NPs are labeled with 19F and their diffusion coefficient is measured using 19F diffusion nuclear magnetic resonance (NMR) spectroscopy, recording a diffusion-ordered nuclear magnetic resonance spectroscopy (DOSY) experiment9. NMR has long been used for structural studies of proteins10,11; however, herein we propose the use of 19F diffusion NMR to observe changes in hydrodynamic radius of NPs upon adsorption of proteins in solution and also in complex media such as blood.
Results
Synthesis and characterization of fluorinated NPs
Three types of Au NPs labeled with fluorinated polyethylene glycol (PEG) ligands were first synthesized. Two of them contained additional PEG chains bearing either –COOH or –NH2 head groups and the third type was further coated with the polymer poly(isobutylene–alt-maleic anhydride) (PMA), which in water also presents –COOH groups at its surface. These three types of NPs are in the following referred to as NP-F/COOH, NP-F/NH2, and NP-F/NH2@PMA and are depicted in Fig. 1a. Transmission electron microscopy (TEM) analysis revealed the following similar radii r c of the gold cores: r c = 1.5 ± 0.7 nm (NP-F/COOH); r c = 1.7 ± 0.6 nm (NP-F/NH2); and r c = 1.7 ± 0.6 nm (NP-F/NH2@PMA). All data are presented as mean value ± standard deviation. NP concentrations were determined by UV/Vis absorption spectroscopy and inductively coupled plasma mass spectrometry (ICP-MS). The NPs were characterized to possess good colloidal stability and zeta potential measurements in water-indicated negative or positive surface charge of the NPs terminated with –COOH or –NH2, respectively: ζ = −13.8 ± 1.1 mV (NP-F/COOH); ζ = +5.7 ± 0.7 mV (NP-F/NH2); and ζ = −36.2 ± 1.2 mV (NP-F/NH2@PMA). All three types of NPs allowed for recording 19F-NMR signal in the form of a single peak.
Size calculation based on 19F diffusion NMR
Using 19F diffusion NMR measurements, the following diffusion coefficients (D) for these NPs in water were obtained: D = (2.73 ± 0.03)×10−11 m2/s (NP-F/COOH); D = (2.86 ± 0.04)×10−11 m2/s (NP-F/NH2); and D = (3.39 ± 0.29)×10−11 m2/s (NP-F/NH2@PMA). Based on the Stokes–Einstein relation, the following hydrodynamic radius r h in water could be derived from the diffusion coefficients, similar to approaches reported in literature12: r h = 8.99 ± 0.08 nm (NP-F/COOH); r h = 8.57 ± 0.12 nm (NP-F/NH2); and r h = 7.25 ± 0.63 nm (NP-F/NH2@PMA). As expected, the hydrodynamic radii r h were a few nm larger than the core radii r c, accounting for the size of the hydrated ligand shell, which is not visible in TEM13. This confirmed the general possibility of measuring hydrodynamic radii of 19F-labeled NPs with 19F diffusion NMR. The obtained hydrodynamic radii were confirmed by DLS (see Supplementary Tables 15 and 16), and are also in agreement with data obtained with FCS with similar (fluorescence-labeled) NPs. Similar NPs with PEG or PMA surface coating have also been demonstrated to be highly colloidally stable, also in the presence of NaCl and proteins14. In addition, NPs with different surface chemistry and larger overall radius were synthesized as control and thoroughly characterized, and their hydrodynamic radii were determined with 19F diffusion NMR (see Supplementary Tables 23 and 24). Results indicate that the here proposed method is stable in case the 19F labels are introduced without PEG, and theoretically for NPs with hydrodynamic radii as large as 100 nm, as long as sufficient 19F-NMR signal is detectable. However, our measurements are highly dependent on the T 2 values and concentration of fluorine, which will certainly limit the diffusion coefficients (D) measurement for nanomaterials of such large size.
Protein corona study based on 19F diffusion NMR
As a next step, protein adsorption to the different NPs based on increase in their hydrodynamic radii was probed by 19F diffusion NMR, using protocols similar to those used with FCS in previous reports6. As starting point, artificial protein coronas were generated by covalent linkage of human serum albumin (HSA) or human apo-transferrin (aTR) to the surface of NP-F/COOH through N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) chemistry. The amount of attached proteins was hereby controlled by the EDC concentration. For each condition, the number of bound proteins per NP (N HSA/NP, N aTR/NP) was determined by Bradford assay. At the maximum EDC concentration possible without interfering with the colloidal stability of the NPs 5.21 ± 0.17 and 1.76 ± 0.01 HSA and aTR protein molecules, respectively, could be bound per NP. For all conditions the hydrodynamic radii of the NP–protein complexes were determined by 19F diffusion NMR measurements. In Fig. 1b, c, the increase in hydrodynamic radii in dependence of the number of attached proteins is shown. As expected, the more proteins are attached per NP, the more the hydrodynamic radii increases, reaching saturation when the maximum possible amount of proteins is attached per NP. Similar measurements of NP–protein size vs. number of attached proteins could be recorded with gel electrophoresis15, but not with standard DLS, where the experimental error was higher than the actual changes in size.
These data motivated for measuring protein adsorption in situ by 19F diffusion NMR. While for DLS free proteins would interfere with analysis, gel electrophoresis separation of NP–protein complexes from free proteins would lead to loss of equilibrium conditions and desorption of proteins from the NP–protein complexes5. In situ detection of protein adsorption in phosphate-buffered saline (PBS) has been reported by FCS6. Here the same principle was carried out with 19F diffusion NMR experiments. HSA was added in different concentrations c HSA to NP-F/NH2@PMA in PBS, and for each concentration the hydrodynamic radius r h of the NP-HSA complexes was measured in situ, i.e., without any purification of unbound HSA excess by 19F diffusion NMR. This was possible as the 19F label was attached to the NPs, and thus the proteins themselves did not provide signal. The data shown in Fig. 2 present the typical sigmoidal curve, as known from FCS measurements6. Using the Hill model, the maximum number of adsorbed HSA molecules per NP was determined as N HSA/NP(max) = 65.6 ± 2.6, HSA adsorption is cooperative with a Hill coefficient of n = 2.3 ± 0.2, the apparent dissociation coefficient is = 13.6 ± 0.9 μM, and under saturation conditions the HSA corona forms a monolayer with the thickness Δr h = 4.87 ± 0.08 nm around the NPs. These values are on the same order of magnitude as those derived from FCS measurements on PMA-coated surfaces6. Note that in the geometry used here, the PEGylated 19F-ligands are overcoated by PMA. In contrast, no HSA adsorption was found in the investigated range for NP-F/COOH and NP-F/NH2 (Fig. 2). For these NPs, the 19F-ligands are directly exposed to the surface. FCS measurements on similar NPs have shown that PEGylation reduces protein adsorption16. In case of mushroom-like coating, proteins may penetrate the PEG layer, and thus still contribute to a slight increase of the hydrodynamic radius. In case of tight PEG layers, as expected in the present case due to the direct linkage of the PEG ligands via thiols, suppression of protein adsorption is expected. In addition, the fluorine head groups also could repel proteins17. Effects of fluorination on protein adsorption have been discussed in the literature, mainly for planar surfaces18,19. In additional control experiments, we could show that in fact the hydrophobicity associated with fluorine head groups had effect on the interaction with fibrinogen (see Supplementary Figs. 49 and 50). Hydrodynamic radii increase upon natural adsorption of transferring (TR) on NP-F/NH2@PMA was also studied (see Supplementary Fig. 30). Taken together, our data demonstrate that 19F diffusion NMR experiments can be used for the in situ quantification of protein adsorption.
Protein corona study in complex media with 19F diffusion NMR
The data shown in Fig. 2 were recorded under well-defined conditions, in which besides the NPs, only one type of protein, in this case HSA, was present in solution. As there were no impurities able to scatter and attenuate light, comparable analysis can be performed also with optical interrogation, such as FCS6, instead of NMR. We thus wanted to perform experiments in complex media, in order to highlight the possibilities of 19F diffusion NMR experiments. All three types of NPs were exposed either to whole blood, or to blood plasma, which was donated by one of the coauthors (C. C.–C.), and the resulting diffusion coefficients of the NPs were measured in situ by 19F diffusion NMR. These measurements were indeed possible due to the absence of interfering fluorinated molecules in physiological media; hence the signal detected in 19F-NMR belongs unequivocally to the NPs. The results shown in Fig. 3 first prove that there is no agglomeration of the NPs either in blood or in plasma. As no drastic increase in size was observed, we can conclude that all three types of NPs remained colloidally stable and well dispersed in blood and plasma. Incubation in blood did not largely change the hydrodynamic radii of the NPs as compared to dispersion in PBS. However, in the case of NP-F/NH2@PMA incubation in plasma resulted in a size increase of ca. 5.5 nm, comparable to that under saturation exposure with HSA. Thus, also in the case of plasma, there was protein adsorption, leading to a controlled thin (mono)-layer of proteins around the NPs, whereby the composition, i.e., the types of proteins, is not known. For this, NPs would have to be extracted, excess proteins removed, and the composition of the corona analyzed for example by mass spectroscopy3. However, the experimental finding that even in a complex mixture of proteins and other molecules as lipids there is a defined thin corona, is in agreement with data from the literature20. In the case of NP-F/COOH and NP-F/NH2, there was some decrease of size observed in plasma, while under saturation with HSA the size of these NPs was similar to that recorded in PBS. This might be explained by shrinkage of the PEG-containing ligands in plasma, as it has been reported by other groups12,21,22. Data indicate that it is possible to make NPs that remain well dispersed in blood and plasma, and that 19F diffusion NMR allows for in situ analysis of the state of dispersion and protein corona formation, without the need of any purification.
As magnetic fields are not adsorbed by tissue, measurements of hydrodynamic radii of 19F-labeled NPs could also be possible in vivo. Hereby, the expected signal-to-noise ratio becomes critical. In order to obtain sufficient signal, the amount of injected NPs needs to be maximized, while still avoiding toxic side effects. Signal-to-noise ratio can also be increased by longer scanning times, which, however, would result in losing the capability of observing time-dependent changes on shorter time scales. While at the present stage, we are not able to manifest our vision with experimental in vivo data, we have estimated that injection of 200 µL of 2.7 µM NP-F/COOH solution into a mouse should allow for in situ detection of 19F signal requiring scanning times on minute time scales (see Supplementary Fig. 72). However, since in diffusion NMR, a signal intensity loss is measured, which is in addition dependent on the specific gradients applied, at this stage it is difficult to predict whether this NP-F/COOH concentration would be enough or not. Further improvement could be achieved by increasing the 19F density on the surface of the NPs and/or the fluorinated probe concentration.
After in vivo administration, NPs would circulate in the blood flow, surrounded by the cellular walls of the blood vessels. For most applications, long circulation times are desired. We emulated this scenario by adding NP-F/COOH to suspensions of THP-1 cells. Due to their PEG coating, the NPs are not supposed to be strongly incorporated by cells23, i.e., these NPs would be expected to have decent circulation times. The hydrodynamic radii of the NPs above cells could in fact be measured by NMR and led to similar results as obtained on plain NP solutions (see Supplementary Fig. 69).
Discussion
Still, interpretation of future in vivo results may turn out complex. In case NPs are endocytosed by macrophages (which could be partly prevented by PEGylation), they would be confined to endosomes/lysosomes, which in fact could affect diffusion measurements. After intravenous injection in situ characterization of NPs directly in vivo could result in the following scenarios. Agglomeration of NPs could be detected as drastic increase in their effective hydrodynamic radii. Degradation of NPs, in particular partial loss of the surface coating24, would lead to substantial decrease in hydrodynamic radii. Last but not least, adsorption of proteins would be observed as small increase in NP size, depending on the type of NP used. Our methodology is merely based on measuring diffusion constants to obtain hydrodynamic radii, and is thus insensitive to information on a molecular level. While interpretation of change of hydrodynamic radii in vivo will not be straightforward as outlined in the different scenarios above, still these measurements potentially set the pavement for future in situ monitoring of the geometric properties of NPs in vivo.
19F diffusion NMR-mediated measurements of hydrodynamic radii allow for in situ characterization of NPs in complex environments. This has been demonstrated with the quantification of protein adsorption to the surface of NPs, as determined by the increase in hydrodynamic radius. However, for soft coatings, such as PEG, protein interactions may be difficult to assess due to the coating compressibility, which may not lead to r h increase. The methodology is not optics based, and thus can also be used in turbid environment, as for example under the presence of cells. While several obstacles need to be solved, the presented methodology in principle may provide an opportunity to measure hydrodynamic radii of NPs in vivo. Realizing this vision would be an important step toward understanding what is going on in vivo after NPs have been administered.
Methods
Fluorine-labeled NP synthesis
Fluorinated PEG (3 kDa) ligands were prepared by simple synthetic transformations from the corresponding commercially available thiol-protected hydroxyl-ending PEG compound. First, PEG starting material was mesylated and further substituted by perfluorinated sodium tert-butoxide. After acidic deprotection in the presence of trifluoroacetic acid, the so-obtained thiol ligands were used to prepare NP-F/COOH and NP-F/NH2 by combining them with commercially available carboxyl and amino functionalized PEG ligands in the presence of HAuCl4 and NaBH4 as reducing agent and in dichloromethane as the main solvent. Once the organic solvent was evaporated, NPs were resuspended in water and purified by ultracentrifugation at 1.5×105 g to remove unbound ligands and very small NPs. Aggregates and bigger NPs were also removed by further centrifugation at 5×104 g. Subsequently, NP-F/NH2 was further reacted with PMA in a mixture of dichloromethane and tetrahydrofuran overnight. Excess of PMA was removed by several cycles of centrifugation at 2×103 g and further treated with NaOH (aq.) to obtain NP-F/NH2@PMA. All three types of NPs were characterized by TEM, UV-Vis, 19F-NMR, and Zeta potential. Full synthetic details and characterization of ligands and NPs is provided in the Supplementary Methods.
NP diffusion measurement by 19F-NMR
All diffusion experiments were performed in 5 mm standard NMR tubes filled with a minimum sample volume of 465 µL and a coaxial insert carrying 100 μL of a TFA solution in D2O (0.024% v/v). All glassware were rinsed three times with the corresponding buffer used for each sample (HEPES or PBS) before sample loading. For the measurements of natural adsorption of HSA, all glassware were passivated with a solution of HSA (10 mg/mL) for 15–30 min and then rinsed three times with PBS. All NMR data were collected on a Bruker AVANCE III NMR spectrometer (11.7 T, 470.59 MHz for 19F) equipped with a 5 mm1H/19F BBI probe with actively shielded z-gradient that was used in combination with a Bruker gradient amplifier providing a maximum current of 10 A, which results in a 65 G/cm gradient. 19F diffusion NMR measurements were performed using stimulated echo with bipolar gradient pulses from Bruker’s sequence library (stebpgp1s) with the following parameters: 4k acquisition points, SW 15 ppm, NS ≥ 480, DS 32, D1 2 s, D20 (little delta) 0.5 s, P30 (big Delta/2) 1.5 ms, and 12 equally spaced gradient strengths from 5 to 95%. NMR measurements were performed using deuterium lock and while the sample was spinning.
Calculation of rh from 19F diffusion NMR measurements
Diffusion constants (D) for each sample were calculated by fitting the NMR signal intensity (I) decay in the diffusion 19F-NMR spectra to a mono-exponential decay (Eq. (1)) with a scaling factor A:
1 |
where Z is the gradient strengths used in the measurement.
D values were obtained in this manner as the average of at least two measurements. The hydrodynamic radius r h for each NP sample was calculated using the so-obtained diffusion constant D and applying the Einstein–Stokes relation (Eq. (2)), assuming spherical shape for NPs:
2 |
where η is the dynamic viscosity, T is the absolute temperature, and k B is the Boltzmann constant.
Data availability
All data are available from the authors on reasonable request.
Electronic supplementary material
Acknowledgments
This work was supported by the German Research Foundation (DFG grant DFG Grant PA 794/25-1 to W.J.P.). Parts of this work were funded by MINECO (CTQ2015-68413-R to M.C.). M.C. acknowledges Ikerbasque for a Research Fellow position. C.C.-C. acknowledges MINECO for a Juan de la Cierva—Incorporación contract. P.d.P. acknowledges financial support from MINECO (RYC-2014–16962), the Xunta de Galicia (Centro singular de investigación de Galicia accreditation 2016–2019, ED431G/09), and the European Union (European Regional Development Fund—ERDF). The authors acknowledge technical assistance by Javier Calvo for high-resolution mass spectroscopy measurements and Karsten Kantner for ICP-MS measurements.
Author contributions
M.C., P.d.P. and C.C.C. prepared and characterized the fluorinated NPs and did data analysis and diffusion measurements. D.P. optimized diffusion protocols and did diffusion measurements. M.G. purified and characterized the fluorinated NPs. W.J.P. conceived the idea and designed the research. All authors contributed to results, discussion, and manuscript writing.
Competing interests
The authors declare no competing financial interests.
Footnotes
Electronic supplementary material
Supplementary Information accompanies this paper at doi:10.1038/s41467-017-01826-4.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Monica Carril, Email: mcarril@cicbiomagune.es.
Wolfgang J. Parak, Email: wparak@cicbiomagune.es
References
- 1.Pelaz B, et al. Diverse applications of nanomedicine. ACS Nano. 2017;11:2313–2381. doi: 10.1021/acsnano.6b06040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lundqvist M, et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano. 2011;5:7503–7509. doi: 10.1021/nn202458g. [DOI] [PubMed] [Google Scholar]
- 3.Tenzer S, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 2013;8:772–U1000. doi: 10.1038/nnano.2013.181. [DOI] [PubMed] [Google Scholar]
- 4.Setyawati MI, Tay CY, Docter D, Stauber RH, Leong DT. Understanding and exploiting nanoparticles’ intimacy with the blood vessel and blood. Chem. Soc. Rev. 2015;44:8174–8199. doi: 10.1039/C5CS00499C. [DOI] [PubMed] [Google Scholar]
- 5.del Pino P, et al. Protein corona formation around nanoparticles—from the past to the future. Mater. Horiz. 2014;1:301–313. doi: 10.1039/C3MH00106G. [DOI] [Google Scholar]
- 6.Röcker C, Pötzl M, Zhang F, Parak WJ, Nienhaus GU. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat. Nanotechnol. 2009;4:577–580. doi: 10.1038/nnano.2009.195. [DOI] [PubMed] [Google Scholar]
- 7.Balog S, et al. Characterizing nanoparticles in complex biological media and physiological fluids with depolarized dynamic light scattering. Nanoscale. 2015;7:5991–5997. doi: 10.1039/C4NR06538G. [DOI] [PubMed] [Google Scholar]
- 8.Hadjidemetriou M, et al. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS Nano. 2015;9:8142–8156. doi: 10.1021/acsnano.5b03300. [DOI] [PubMed] [Google Scholar]
- 9.Barjat H, Morris GA, Smart S, Swanson AG, Williams SCR. High-resolution diffusion-ordered 2D spectroscopy (Hr-Dosy)—a new tool for the analysis of complex-mixtures. J. Magn. Reson. B. 1995;108:170–172. doi: 10.1006/jmrb.1995.1118. [DOI] [Google Scholar]
- 10.Lundqvist M, Sethson I, Jonsson BH. High-resolution 2D H-1-N-15 NMR characterization of persistent structural alterations of proteins induced by interactions with silica nanoparticles. Langmuir. 2005;21:5974–5979. doi: 10.1021/la050569j. [DOI] [PubMed] [Google Scholar]
- 11.Haussinger D, et al. Calcium-dependent homoassociation of E-cadherin by NMR spectroscopy: changes in mobility, conformation and mapping of contact regions. J. Mol. Biol. 2002;324:823–839. doi: 10.1016/S0022-2836(02)01137-3. [DOI] [PubMed] [Google Scholar]
- 12.Porsch C, et al. In vitro evaluation of non-protein adsorbing breast cancer theranostics based on 19F-polymer containing nanoparticles. Part. Part. Syst. Char. 2013;30:381–390. doi: 10.1002/ppsc.201300018. [DOI] [Google Scholar]
- 13.del_Pino P, et al. Basic physicochemical properties of polyethylene glycol coated gold nanoparticles that determine their interaction with cells. Angew. Chem. Int. Ed. Engl. 2016;55:5483–5487. doi: 10.1002/anie.201511733. [DOI] [PubMed] [Google Scholar]
- 14.Huhn J, et al. Selected standard protocols for the synthesis, phase transfer, and characterization of inorganic colloidal nanoparticles. Chem. Mater. 2017;29:399–461. doi: 10.1021/acs.chemmater.6b04738. [DOI] [Google Scholar]
- 15.Hühn J, et al. Dissociation coefficients of protein adsorption to nanoparticles as quantitative metrics for description of the protein corona: A comparison of experimental techniques and methodological relevance. Int. J. Biochem. Cell. Biol. 2016;75:148–161. doi: 10.1016/j.biocel.2015.12.015. [DOI] [PubMed] [Google Scholar]
- 16.Pelaz B, et al. Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake. Acs Nano. 2015;9:6996–7008. doi: 10.1021/acsnano.5b01326. [DOI] [PubMed] [Google Scholar]
- 17.Cai XJ, et al. Bioreducible fluorinated peptide dendrimers capable of circumventing various physiological barriers for highly efficient and safe gene delivery. ACS Appl. Mater. Interfaces. 2016;8:5821–5832. doi: 10.1021/acsami.5b11545. [DOI] [PubMed] [Google Scholar]
- 18.Wang D, Douma M, Swift B, Oleschuk RD, Horton JH. The adsorption of globular proteins onto a fluorinated PDMS surface. J. Colloid Interface Sci. 2009;331:90–97. doi: 10.1016/j.jcis.2008.11.010. [DOI] [PubMed] [Google Scholar]
- 19.Hu K, et al. Fluorinated silicon surfaces under mixed surfactants: resistance to nonspecific protein adsorption for biosensing. Langmuir. 2009;25:12404–12407. doi: 10.1021/la901588x. [DOI] [PubMed] [Google Scholar]
- 20.Wang H, et al. The nature of a hard protein corona forming on quantum dots exposed to human blood serum. Small. 2016;12:5836–5844. doi: 10.1002/smll.201602283. [DOI] [PubMed] [Google Scholar]
- 21.Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006;307:93–102. doi: 10.1016/j.ijpharm.2005.10.010. [DOI] [PubMed] [Google Scholar]
- 22.Wolfram J, et al. Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf. B. 2014;114:294–300. doi: 10.1016/j.colsurfb.2013.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lipka J, et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials. 2010;31:6574–6581. doi: 10.1016/j.biomaterials.2010.05.009. [DOI] [PubMed] [Google Scholar]
- 24.Kreyling WG, et al. In vivo integrity of polymer-coated gold nanoparticles. Nat. Nanotechnol. 2015;10:619–623. doi: 10.1038/nnano.2015.111. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data are available from the authors on reasonable request.